HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Svetlana A Limborska Selected Research

methionylglutamic acid

6/2021Brain Protein Expression Profile Confirms the Protective Effect of the ACTH(4-7)PGP Peptide (Semax) in a Rat Model of Cerebral Ischemia-Reperfusion.
3/2014The peptide semax affects the expression of genes related to the immune and vascular systems in rat brain focal ischemia: genome-wide transcriptional analysis.
2/2013Effect of semax and its C-terminal fragment Pro-Gly-Pro on the expression of VEGF family genes and their receptors in experimental focal ischemia of the rat brain.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Svetlana A Limborska Research Topics

Disease

8Brain Ischemia (Cerebral Ischemia)
11/2021 - 01/2008
7Ischemia
11/2021 - 01/2008
6Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
06/2022 - 01/2010
5Stroke (Strokes)
06/2022 - 01/2010
3Ischemic Stroke
06/2021 - 02/2013
1Inflammation (Inflammations)
06/2021
1Atherosclerosis
09/2020
1Coronary Stenosis (Coronary Artery Stenosis)
09/2020
1Cholesteryl Ester Transfer Protein Deficiency
09/2020
1Brain Injuries (Brain Injury)
06/2017
1Parkinson Disease (Parkinson's Disease)
01/2015
1Ovarian Neoplasms (Ovarian Cancer)
02/2014
1Parkinsonian Disorders (Parkinsonism)
08/2003
1Movement Disorders (Movement Disorder)
08/2003
1Dopa-responsive Dystonia
08/2003

Drug/Important Bio-Agent (IBA)

7Peptides (Polypeptides)IBA
06/2021 - 01/2010
6Pro-Gly-Pro- ACTH (4-7)IBA
06/2021 - 01/2010
4RNA (Ribonucleic Acid)IBA
06/2022 - 09/2018
3histidyl- phenylalanyl- prolyl- glycyl- prolineIBA
06/2021 - 02/2013
3methionylglutamic acidIBA
06/2021 - 02/2013
3prolyl-glycyl-prolineIBA
06/2017 - 01/2010
2salicylhydroxamic acid (SHAM)IBA
06/2022 - 09/2018
2Circular RNAIBA
11/2021 - 03/2019
2Nerve Growth Factors (Neurotrophins)IBA
06/2021 - 01/2010
2ACTH (4-7)IBA
06/2017 - 01/2010
2Messenger RNA (mRNA)IBA
01/2010 - 01/2008
1Genetic Markers (Genetic Marker)IBA
11/2021
1MelanocortinsIBA
06/2021
1Proteins (Proteins, Gene)FDA Link
06/2021
1Neurotransmitter Agents (Neurotransmitter)IBA
06/2021
1Matrix Metalloproteinases (MMPs)IBA
06/2021
1oxidized low density lipoproteinIBA
09/2020
1HDL CholesterolIBA
09/2020
1Protein Kinase C-thetaIBA
09/2020
1Cholesterol Esters (Cholesteryl Esters)IBA
09/2020
1CholesterolIBA
09/2020
1Immunoglobulins (Immunoglobulin)IBA
06/2017
1InterferonsIBA
06/2017
1MicroRNAs (MicroRNA)IBA
01/2015
1Nootropic Agents (Nootropics)IBA
03/2014
1Neuroprotective AgentsIBA
03/2014
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
02/2014
1Cisplatin (Platino)FDA LinkGeneric
02/2014
1XenobioticsIBA
02/2014
1Vascular Endothelial Growth Factor BIBA
02/2013
1Vascular Endothelial Growth Factor DIBA
02/2013
1Therapeutic UsesIBA
02/2013
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2013
1Vascular Endothelial Growth Factor CIBA
02/2013
1SphingomyelinsIBA
01/2008
1EnzymesIBA
01/2008
1phosphatidylcholine-ceramide phosphocholine transferaseIBA
01/2008
1GTP Cyclohydrolase (GTP Cyclohydrolase I)IBA
08/2003
1Dihydroxyphenylalanine (Dopa)IBA
08/2003

Therapy/Procedure

4Therapeutics
01/2015 - 01/2010
2Drug Therapy (Chemotherapy)
01/2015 - 02/2014
1Aftercare (After-Treatment)
01/2010